OMICS A Journal of Integrative Biology · 2018 · 28 citations · 129 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular EpidemiologyMolecular OncologyCancer BiomarkersCervical CancerCervical Intraepithelial NeoplasiaCervical PathologyGynecologic Cancer EpidemiologyHuman Papillomavirus InfectionCase-control Association StudiesHost Genetic VariantsHuman Papillomavirus EpidemiologyOncogenic Viral GenesPopulation Genetic SusceptibilityShared Genetic SusceptibilityWhole Exome Sequencing StudiesWhole Genome Sequencing Studies
Human papillomavirus (HPV) is an essential but not a sufficient cervical cancer etiological factor. Cancer promoters, such as host genetic mutations, significantly modulate therapeutic responses and susceptibility. In cervical cancer, of interest have been viral clearing genes and HPV oncoprotein targets, for which conflicting data have been reported among different populations. This expert analysis evaluates cervical cancer genetic susceptibility biomarkers studied in African populations. Notably, the past decade has seen Africa as a hotbed of biomarker and precision medicine innovations, thus potentially informing worldwide biomarker development strategies. We conducted a critical literature search in PubMed/MEDLINE, Google Scholar, and Scopus databases for case-control studies reporting on cervical cancer genetic polymorphisms among Africans. We found that seven African countries conducted cervical cancer molecular epidemiology studies in one of Casp8, p53, CCR2, FASL, HLA, IL10, TGF-beta, and TNF-alpha genes. This analysis reveals a remarkable gap in cervical cancer molecular epidemiology among Africans, whereas cervical cancer continues to disproportionately have an impact on African populations. Genome-wide association, whole exome- and whole-genome sequencing studies confirmed the contribution of candidate genes in cervical cancer. With such advances and omics technologies, the role of genetic susceptibility biomarkers can be exploited to develop novel interventions to improve current screening, diagnostic and prognostic methods worldwide. Exploring these genetic variations is crucial because African populations are genetically diverse and some variants or their combined effects are yet to be discovered and translated into tangible clinical applications. Thus, translational medicine and flourishing system sciences in Africa warrant further emphasis in the coming decade.
129
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Robert Bierman, Leah Beardsley, Chee‐Jen Chang et al. · New England Journal of Medicine · 1998 · 2.3K citations · Full text
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Guido Ruggero Loria, R Obert B Ierman, L Eah B Eardsley et al. · 1998 · 1.9K citations
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Alan Storey, Miranda Thomas, Ann Kalita et al. · Nature · 1998 · 983 citations